USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
06-Aug-2013
Asia Pacific
Market Research
P706-01-00-00-00
LS00059-AP-MR_16900
The IVD market in China presents diversified growth potential for different tiers of participants: domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the high-end market. This research service analyzes the IVD market and provides forecasts and opportunities by understanding the market dynamics and trends. The market can be divided into segments such as clinical chemistry, immunoassay, molecular biology diagnostics, microbiology, coagulation, and hematology. The study covers the period 2007-2016.
Executive Summary
Executive Summary (continued)
Executive Summary—Market Engineering Measurements
Past, Present, and Future IVD Market in China
Snapshot of Potential Opportunities
Opportunities in Emerging Segments
Market Overview—Segmentation by Testing Principle
Market Overview—Segmentation(continued)
Market Overview—Segmentation (continued)
Market Life Cycle
Healthcare Structure and Financing in China
Overview of the Chinese Medical Insurance System
Overview of the Chinese Medical Insurance System (continued)
Approval of IVD Products
Procurement of IVD Products
Reimbursement and Price Caps
In Vitro Diagnostics Overview
Drivers and Restraints
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Total IVD Market —Market Engineering Measurements
Forecast Assumptions
Total IVD Market—Revenue Forecast
Revenue Forecast Discussion
Multinational and Local Participants
Foreign enterprises have already achieved stable market shares
Leading Local suppliers more flexible on their sales strategy
Distribution Model of IVD Industry
Feature Analysis of the Chinese Health Institution and Central Labs
Develop substitution for imported devices: short-cut for local leading manufacturers
Competitive Analysis—Market Share
Market Share Analysis
Market Share Analysis(continued)
Molecular Diagnostics Segment—Revenue Forecast
Molecular Diagnostics Segment—Revenue Forecast Discussion
Clinical Chemistry Segment—Revenue Forecast
Clinical Chemistry Segment—Revenue Forecast Discussion
Immunoassay Segment—Revenue Forecast
Immunoassay Segment—Revenue Forecast Discussion
Microbiology Segment—Revenue Forecast
Microbiology Segment—Revenue Forecast Discussion
POCT Segment—Revenue Forecast
POCT Segment—Revenue Forecast Discussion
Coagulation Segment—Revenue Forecast
Coagulation Segment—Revenue Forecast Discussion
SMBG Segment—Revenue Forecast
SMBG Segment—Revenue Forecast Discussion
Hematology Segment—Revenue Forecast
Hematology Segment—Revenue Forecast Discussion
Conclusions
Recommendations
Legal Disclaimer
Who is Frost & Sullivan
What Makes Us Unique
TEAM Methodology
Our Global Footprint 40+ Offices
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| WIP Number | P706-01-00-00-00 |
| Is Prebook | No |
In Vitro Diagnostics (IVD) Market Outlook in China
$4,950.00
Special Price $3,712.50 save 25 %